• יו"ר: דר' מאיר מי-זהב
  • גזבר: דר' רונן בר-יוסף
  • עורך האתר: דר' אופיר בר-און
  • חברי ועד: פרופ׳ אלי פיקאר (מזכיר)
  • פרופ׳ אביב גולדברט
  • דר' מורן לביא
  • דר׳ מאלנה כהן-סימברקנאו
  • דר׳ פאהד חכים
Conferences and Presentations

The Yearly CF Meeting - October 2021

כנס CF שנתי | נתניה | אוקטובר 2021

ריאות (אילוסטרציה)
ריאות (אילוסטרציה)

Venous Thromboembolism and Anticoagulation Considerations in CF Patients, Tal Lavi

Respiratory Physiotherapy in CF Patients and Upper Limb DVT, Tomer Israeli

Personalized Exercise Prescription, Dr. Ronen Bar-Yoseph

Continuation of Care From Near And Far, Hadas Mantin, Eynav Manor

Extended Protocol for Bowel Preparation in Adult CF Undergoing Screening Colonoscopy, Hila Alterovich

The Israeli CF Database, Dr. Meir Mei-Zahav

The Effect of National Population Carrier Screening Program on CF Birth Rate, Genotype and Phenotype, Dr. Miri Dotan

The Association Between CFTR Function and Ventilation Inhomogeneity, Dr. Oded Breuer

Rabin Medical Center, CF Transition Experience, Dr. Moshe Heching

Time For Lung Transplant in CF - Seek Under the Spirometry Lamp, Dr. Daphna Vilozni

Challenges in Treating Pseudomonas Infection in CF Patients, Prof. Malena Cohen-Cymberknoh

Is There Benefit for Inhaled Antibiotic Maintenance Therapy in CF Patients Without Chronic Pseudomonas Infection, Dr. Michal Shteinberg

Clinical Outcomes Associated with Achromobacter Infection in CF Patients, Cross Sectional Analysis ECFSPR Data, Prof. Eitan Kerem

COVID19 and Cystic Fibrosis, Dr. Meir Mei-Zahav

BiomX, Nebulized Bacteriophage Therapy for Chronic Pseudomonas Pulmonary Infections in Cystic Fibrosis Patients

Pregnancy and Cystic Fibrosis, Dr. Lior Tsviban

Multigravida Cystic fibrosis Patients, Maternal and Fetal Outcomes, Maya Dabby

ELX-02 Development in CF Update

2D Intestinal Organoids For Personalized Medicine in CF, Dr. Liron Birimberg-Schwartz

Antisense Oligonucleotide Splicing Modulation As Novel CF Therapeutic Approach For W1282X Mutation, Prof. Batsheva Kerem

IVA-TEZ-ELX Clinical Overview for 6-11 Year-Olds, Dr. Dario Prais

Triple Therapy CFTR Modulators, Literature Review and Israeli Experience, Dr. Adi Dagan

Is Primary Sclerosing Cholangitis a Cystic Fibrosis Related Disorder, Prof. Michael Wilschanski

31 The Association Between IgG and Disease Severity Parameters in CF Patients, Dr. Michal Gur

32 Sleep Disturbances in CF and PCD Over Time, Before and After Modulator Therapy, Maya Lehavi

33 The Changing Face of CF, Dr. Eddie Landau

34 Hybrid Medicine, A Bridge To The Future, Dr. Ifat Sarouk

נושאים קשורים:  Conferences and Presentations
תגובות